| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/18/2007 | WO2007007119A1 Processes for the manufacture of rosuvastatin and intermediates |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2006115895A3 Phenyl ethyne compounds |
| 01/18/2007 | WO2006114572A3 Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes |
| 01/18/2007 | WO2006110608A3 Compositions and method for increasing the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors |
| 01/18/2007 | US20070015918 Derivatives of 1,3-diones having a herbicidal activity |
| 01/18/2007 | US20070015778 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015773 Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015734 Mao-b inhibitors useful for treating obesity |
| 01/18/2007 | CA2614281A1 Processes for the manufacture of rosuvastatin and intermediates |
| 01/17/2007 | EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function |
| 01/17/2007 | EP1743011A1 Electroluminescent device |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742925A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidine-2-yl compounds and 5, 6, 7, 8-tetrahydro-quinazoline-2-yl compounds |
| 01/17/2007 | EP1742924A1 Calcilytic compounds |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1898233A Process for the manufacture of the calcium salt of rosuvatatin (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystallin |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898215A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/17/2007 | CN1898208A Amide derivative and medicine |
| 01/17/2007 | CN1896084A Non-sedating barbituric acid derivatives |
| 01/17/2007 | CN1295242C 3'-prodrugs of 2'-deoxy-beta-L-nucleosides |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/16/2007 | US7164019 Such as cyclopentanecarboxylic acid {(S)-1-phenyl-3-[5-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-propyl}-amide; antagonists of chemokine receptors, useful for treating/preventing human immunodeficiency virus infection, AIDS or ARC |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163941 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2007003596A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 01/11/2007 | WO2007003486A1 Method for the production of quinazolinone derivatives |
| 01/11/2007 | WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 01/11/2007 | WO2006091771A3 Preparation of rosuvastatin |
| 01/11/2007 | WO2006078886A3 Compounds and compositions as wnt signaling pathway modulators |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010668 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/11/2007 | US20070010540 ;Crystal proteins; antineoplastic agents for colon or breast carcinoma; diamino-pyrimidine Colony stimulating factors (cFMS) inhibitors like 5-{3-methoxy-4-[(4-methoxybenzyl)oxy]benzyl}pyrimidine-2,4-diamine; drug screening |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | CA2627590A1 Method for the production of quinazolinone derivatives |
| 01/11/2007 | CA2613664A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 01/11/2007 | CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 01/10/2007 | EP1663991B1 Selective synthesis of cf3-substituted pyrimidines |
| 01/10/2007 | CN1894258A Compositions useful as inhibitors of protein kinases |
| 01/10/2007 | CN1894255A 6-(aminocarbonyl-phenyl)triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 01/10/2007 | CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors |
| 01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 01/10/2007 | CN1894221A Reference standard for characterization of rosuvastatin |
| 01/10/2007 | CN1894220A Herbicidal pyrimidines |
| 01/10/2007 | CN1894202A Benzoyl-substituted phenylalanine amides |
| 01/10/2007 | CN1893951A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/10/2007 | CN1891704A Dipetidase tetrainhibitor, and its preparing method and use |
| 01/10/2007 | CN1891701A Heteraromatic ring thiosemicarbazone compound, and its derivatives and their use forpreparing antitumour medicine |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/10/2007 | CN1294121C Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
| 01/09/2007 | US7161172 Using fluorine substituted 2-phenylpyridine, phenylpyrimidine or phenylquinoline compound |
| 01/09/2007 | US7161004 Processes to produce intermediates for rosuvastatin |
| 01/09/2007 | US7161002 Compounds as antiinflammartory agents, antiproliferation agents and and anticancer agents from cyclodehydration of compounds |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 01/09/2007 | US7160890 N-6 Substituted 7-deazapurines selectively binding to the adenosine 3 receptor; bronchitis, gastrointestinal disorders, asthma, allergic rhinitis, chronic obstructive pulmonary disease, vision defects, arthritis, autoimmune disease |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007002701A2 Anti-inflammatory aryl nitrile compounds |
| 01/04/2007 | WO2007000393A1 8-alk0xy-4-methyl-3 , 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 01/04/2007 | WO2007000121A1 A method for the production of the hemi-calcium salt of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/04/2007 | WO2007000098A1 SUBSTITUTED p-TRIFLUOROMETHYL PHENYLETHERS, THE PREPARATIO AND THE USE THEREOF |
| 01/04/2007 | WO2006125194A3 Piperazine derivatives and their uses as therapeutic agents |
| 01/04/2007 | WO2006108714A3 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 01/04/2007 | WO2006103677A3 Exogenous markers for oxidative stress |
| 01/04/2007 | WO2006039325A3 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004742 Arylpiperazinyl compounds |
| 01/04/2007 | US20070003707 Photochemical Crosslinkers for Polymer Coatings and Substrate Tie-Layer |
| 01/04/2007 | CA2612585A1 Anti-inflammatory aryl nitrile compounds |
| 01/04/2007 | CA2612478A1 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 01/04/2007 | CA2612460A1 Chloro-substituted guanidines |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 01/03/2007 | EP1737832A1 Compounds derived from 4-anilinequinazolines with adenosine-kinase inhibitor properties |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737830A1 Tri-substituted ureas as cytokine inhibitors |